News
February 5, 2008 – A medical team led by Adrian Ebner, M.D., of French Hospital and Lutz Buellesfeld, M.D. of Helios ...
February 04, 2008
Technology
CardioDynamics recently received market clearance from the FDA for its BioZ Impedance Cardiography (ICG) clinical ...
February 04, 2008
Feature | Amy Lillard
When cardiologists send their high-risk patients home, they may be protected with a host of tools, including implantable cardiac devices and pacemakers and strict regimens of medications. While the tools and regimens are powerful, cardiologists know that they are still limited when it comes to preventing adverse events. Without constant check-ups, serious coronary issues can occur.
February 04, 2008Sponsored Content
Feature | Thrombectomy Devices
Venous thromboembolism (VTE), and pulmonary embolism (PE) in particular, are among the most complex and dangerous acute ...
June 01, 2026Technology
The latest version of GE’s MUSE 7.0 system reportedly incorporates enhancements in information technology, ECG management processes and clinical report editing in an all-digital environment for paperless workflow.
February 04, 2008News
February 5, 2008 - Premera Blue Cross has revised its Corporate Medical Policy to make Microvolt T-Wave Alternans ...
February 04, 2008News
February 5, 2008 - The Medical Imaging & Technology Alliance (MITA), a division of NEMA, said today that the budget ...
February 04, 2008Sponsored Content
Feature | Cardiac Imaging
Sponsored Content — According to the American Heart Association, cardiovascular disease is the leading cause of death in ...
March 13, 2026
Technology
Medtronic Inc. received FDA clearance of the Reveal DX Insertable Cardiac Monitor (ICM) designed to help physicians identify the cause of unexplained fainting or abnormal heart rhythms, including ventricular tachyarrhythmias (VT), fast ventricular tachyarrhythmias (FVT), bradyarrhythmias and asystole.
February 04, 2008
Feature | Amy Ballard, MEd
Delivering vivid and insightful CT images of the coronary vessels directly into the cardiac catheterization laboratories (cath labs) has proven very effective by helping save staff from re-acquiring images of the heart and boosting patient throughput. But CT images are only part of the bigger picture.
February 04, 2008News
February 4, 2008 – Fluke Biomedical unveiled today new defibrillator and pacemaker analyzer technologies, the Impulse 6000D Defibrillator Analyzer and the Impulse 7000DP Defibrillator/Pacer Analyzer, which are designed to be rugged, portable test instrumentation for biomedical technical professionals to ensure proper operation and ultimate performance of critical life-support cardiac resuscitati
February 03, 2008Sponsored Content
Feature | Nuclear Imaging
Cardiac PET/CT represents a major advancement in cardiovascular diagnostics, offering significant clinical and ...
November 12, 2025News
February 4, 2008 - The Centers for Medicare & Medicaid Services (CMS) announced that after completing a review of its 1986 national non-coverage policy for artificial hearts, its preliminary decision is to provide reimbursement for patients who receive the CardioWest temporary Total Artificial Heart (TAH-t) as part of FDA studies that meet CMS specifications.
February 03, 2008
Technology
Fluke Biomedical's product line of defibrillator and pacemaker analyzer technologies includes the Impulse 6000D ...
February 03, 2008News
February 4, 2008 - InSite One Inc.
February 03, 2008Sponsored Content
Feature
SPONSORED CONTENT — Studycast is a comprehensive imaging workflow system that allows healthcare professionals to work ...
June 17, 2025News
February 1, 2008 - Medical Ventures Corp. signed an agreement to acquire two vascular product development companies ...
January 31, 2008News
February 1, 2008 - Stentys' bifurcated stent was successfully implanted recently into a 49-year-old male patient at the ThoraxCenter, Erasmus Medical Center, Rotterdam, the Netherlands, marking the sixth successful implantation of the Stentys bifurcated stent platform.
January 31, 2008News
February 1, 2008 - Medtronic Inc. has received approval from the FDA for the Endeavor Zotarolimus-Eluting Coronary Stent ...
January 31, 2008